Product Code: ETC13333685 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 & 2031F |
3.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market - Industry Life Cycle |
3.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market - Porter's Five Forces |
3.5 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume Share, By Isotope Type, 2021 & 2031F |
3.7 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Trends |
6 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, 2021 - 2031 |
6.1 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Technetium-99m, 2021 - 2031 |
6.1.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Iodine-131, 2021 - 2031 |
6.1.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Fluorine-18, 2021 - 2031 |
6.1.5 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Carbon-11, 2021 - 2031 |
6.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Diagnostic Imaging, 2021 - 2031 |
6.2.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Therapeutic Applications, 2021 - 2031 |
6.2.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Research and Development, 2021 - 2031 |
6.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By SPECT Radiopharmaceuticals, 2021 - 2031 |
6.4.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By PET Radiopharmaceuticals, 2021 - 2031 |
6.4.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Stable Isotopes, 2021 - 2031 |
7 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Overview & Analysis |
7.1 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 - 2031 |
7.2 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
7.4 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.5 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Overview & Analysis |
8.1 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
8.4 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
8.5 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Overview & Analysis |
9.1 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
9.4 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
9.5 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Overview & Analysis |
10.1 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
10.4 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
10.5 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Overview & Analysis |
11.1 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
11.4 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
11.5 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Overview & Analysis |
12.1 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Isotope Type, 2021 - 2031 |
12.4 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Application Area, 2021 - 2031 |
12.5 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market, Revenues & Volume, By Product Type, 2021 - 2031 |
13 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Key Performance Indicators |
14 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market - Export/Import By Countries Assessment |
15 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market - Opportunity Assessment |
15.1 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Opportunity Assessment, By Isotope Type, 2021 & 2031F |
15.3 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Opportunity Assessment, By Application Area, 2021 & 2031F |
15.4 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Opportunity Assessment, By Product Type, 2021 & 2031F |
16 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market - Competitive Landscape |
16.1 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Revenue Share, By Companies, 2024 |
16.2 Global Nuclear Medicine Radio pharmaceuticals and Stable Isotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |